Taking a Bayesian route to the Triple Crown
This article was originally published in The Gray Sheet
Executive Summary
"If you have a prior set of events of eight positive outcomes and zero negative outcomes, and you have an increasing effect as demonstrated by a win of 11 and one-half lengths at Pimlico, what is the likelihood of Smarty Jones winning the Triple Crown?" John Sladky, MD, Emory University, asks attendees at an FDA/Johns Hopkins University-sponsored symposium on Bayesian statistical analysis May 21. For coverage of how Bayesian approaches can enhance medical device clinical studies, see story: 1CDRH Promotes Bayesian Tool To Speed Approvals; Statistical Rigor Required...
You may also be interested in...
CDRH Promotes Bayesian Tool To Speed Approvals; Statistical Rigor Required
FDA is encouraging medical device firms to consider using Bayesian estimation in clinical trials to streamline regulatory timeframes
COVID-19: Test Developers Focus On New Variants
Researchers discussed ways to ensure COVID-19 diagnostics work for all variants during a recent webinar.
Amunix Raises $117m To Take Novel T-Cell Engager Into The Clinic
Amunix’s XTEN technology for half-life extension and precise drug delivery has been used by multiple partners over the past 15 years, but now the firm is building its own cancer therapy pipeline.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: